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Limited elbow and shoulder movement
Weak grip
A B S T R A C T
We report on a family with occipital horn syndrome (OHS) diagnosed in the proband's late ﬁfties. A novel ATP7A
pathogenic variant (c.4222A > T, p.(Lys1408*)), representing the ﬁrst nonsense variant and the second late
truncation causing OHS rather than classic Menkes disease, was found to segregate in the family. The predicted
maintenance of transmembrane domains is consistent with a residual protein activity, which may explain the
mild clinical presentation.
1. Introduction
Occipital horn syndrome (OHS, OMIM #304150) takes its name
from the pathognomonic occipital horn exostoses. It presents in early to
middle childhood and is characterized by connective tissue and skeletal
manifestations [1,2]. Dysautonomia and subtle cognitive deﬁcits might
be displayed by some OHS patients; neurological manifestations are
predominant in the allelic classic Menkes disease (MD, OMIM
#309400). Both disorders, which represent the ends of a continuum,
display X-linked recessive inheritance and are caused by pathogenic
variants in the ATP7A gene, which codes for a transmembrane copper-
transporting ATPase that cycles between the trans‑Golgi (delivery of
copper to the secreted copper enzymes) and the plasma (export of
surplus intracellular copper) membranes. The phenotypes are mainly
related to a deﬁcient activity of cuproenzymes [2,3]. OHS and mild MD
are usually the consequences of pathogenic variants that would result in
a protein with residual activity, such as splice-site variants which also
produce small amounts of normal protein [4–10]. Truncating variants,
such as exon deletions or nonsense variants, result instead in MD severe
classical form with death in early childhood [7,8]. In addition, a small
number of ATP7A missense variants has been recently shown to cause
adult-onset isolated distal motor neuropathy, which represents a third
distinct phenotype. This neuropathy is mainly caused by subtle defects
in ATP7A intracellular traﬃcking, resulting in preferential localization
of the protein at the plasma membrane [11]. We describe a family with
OHS ﬁrst diagnosed in the proband's late ﬁfties. A novel nonsense pa-
thogenic variant in the ATP7A gene was found to segregate in the fa-
mily.
2. Materials and methods
2.1. Clinical report
The patient's medical history started at the age of 5 years (Fig. 1A),
when he required bladder catheterisation, due to bladder diverticula. At
the age of 47 years he had a 20 cm decrement in height with a forward
spine curvature (Fig. 1B, C), causing shortening of breath, feeding dif-
ﬁculties, worsening of walking, and urinary disturbances. Free of
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catheterisations from the age of 10 years until that of 20, he suﬀered
from neurogenic bladder requiring three to four catheterisations a day.
As a heavy smoker, he also had chronic obstructive pulmonary disease.
Colonic diverticula were diagnosed at the age of 52. Premature teeth
loss and surgery for a left inguinal hernia complete his clinical history.
Physical examination at 57 years showed the features displayed in
Fig. 1B–D, as well as limited extension at the elbows, loose palmar skin,
hyperextensible interphalangeal joints of the hands, and dystrophic
nails. Head circumference was 57 cm (90th p), height 150 cm.
Radiographs of the skeleton demonstrated generalized severe os-
teoporosis (Fig. 1E–G), that contrasted with the occipital horn exostoses
(Supplementary Fig. S1A) and the hyperostosis of the proximal ulna and
radius (Fig. 1E, F). Glenohumeral joint alteration (Fig. S1C), together
with focal hyperostosis of the elbows and dislocation of the head of the
radius into the olecranon (Fig. 1E, F), may explain the patient's inability
to touch his head with his hands and the weak grip, which have been
present since childhood. The ﬁnding of an open anterior fontanel ﬁtted
with a sensation of brain splitting (Fig. S1B). Neuroimaging was pre-
cluded by his inability to enter scanners. The family pedigree is shown
in Fig. 1H.
Informed consent was obtained from all participants; the study was
approved by the Research Ethics Committee of IRCCS Istituto
Auxologico Italiano.
2.2. Molecular analysis
ATP7A exons and intron–exon junctions (GenBank accession no.
NM_000052.6, GRCh37/hg19) were analysed by Sanger sequencing in
the proband's DNA extracted from peripheral blood. Available relatives
were genotyped using exon 22-targeted primers. Variant in silico ana-
lysis was performed by consulting: Ensembl Genome Browser [12],
Single Nucleotide Polymorphism database (dbSNP) [13], and Leiden
Fig. 1. Proband's evolution of the phenotype, his pedigree
and family history, and genetic data. A. Photograph of the
proband at the age of 4–5 years, documenting that pectus
excavatum, ﬂexion of elbows and knees were already
manifested. He used to wear a female swimming suit to
cover pectus excavatum. B, C. Long thin face, high fore-
head, hooked nose, short clavicles, severe angled kyphosis,
bony outgrowths at the elbows, absence of subcutaneous fat
and reduction of muscle mass represent the current phe-
notype. D. Detail of the proband's face showing prominent
orbital arches, iris depigmentation and coarse hair. E–G.
Proband's radiographs of the left elbow, forearm and
column, showing: (E–G) diﬀuse severe osteoporosis; (E, F)
the exostoses at the head of ulna and radius and its dis-
location; (F) metaphyseal ﬂaring and dyaphiseal wavy
contours of long bones; (G) wedge-shaped D11 vertebrae,
representing the fulcrum of his severe-angled kyphosis, and
L1 vertebrae. H. Filled symbol and symbols ﬁlled in lighter
color represent, respectively, the proband and his two
possibly more mildly aﬀected male relatives (see the details
in the clinical report). Female carriers of the pathogenic
variant are shown with a dot inside the symbol; asterisk,
members genotyped in the study; [m.i.], pathogenic variant
inferred; y, years. I. From top to bottom: electropherograms
of the ATP7A gene sequence of wild type (III-3), carriers (II-
1, III-1, and IV-2), and the proband (III-2); schematic view
of ATP7A cDNA and protein structure showing in red the
approximative position of the pathogenic variant (modiﬁed
from [24]). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version
of this article.)
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Open Variation Database (LOVD) ATP7A [14].
3. Results
Blood chemistries demonstrated in the proband low serum levels of
copper (40 μg/dL, reference 70–140) and ceruloplasmin (12 mg/dL,
reference 20–60). ATP7A sequencing revealed a novel nonsense pa-
thogenic variant in exon 22 (c.4222A > T, p.(Lys1408*)) (Fig. 1I),
which was never reported in either healthy subjects or MD/OHS pa-
tients. The patient's mother (II-1), the eldest of his two sisters (III-1),
and her daughter (IV-2) were found to carry the pathogenic variant
(Fig. 1H, I).
4. Discussion
We have described a cognitively normal OHS male, being much
older than most OHS or mild MD patients reported in literature [3,14].
The most disabling features were provoked by severe osteoporosis. In-
heritance of the pathogenic variant from the patient's mother (Fig. 1H,
II-1) suggests that his maternal uncle (II-2) and granduncle (I-2) could
also be aﬀected by OHS. Indeed, they both experienced limited move-
ments of shoulders/upper limbs that suggest the presence of the typical
OHS skeletal ﬁndings described in the proband (Fig. S1). Moreover, the
reported presence of coarse hair in the maternal uncle (II-2) and
grandmother (I-1) [10], a possible obligate carrier of the pathogenic
variant, further supports this hypothesis.
All the reported ATP7A truncating variants, either early or late
[8,14,15], cause the classic/severe-classic form of MD, except for the
pathogenic variant described by Dagenais et al. [16] and that reported
here. Speciﬁcally, the OHS family described by Dagenais et al. [16] was
found to carry a frameshift variant (c.4352delG) at codon 1451 in exon
23, which gave rise to 13 novel amino acids before a premature stop
codon. Apart from the low-average range IQ, the proband's phenotype
seems to overlap that of the present patient. In addition, as a result of
late truncating variants, both ATP7A transcripts are predicted to lack
the distal di–leucine motif, which is considered essential for the protein
recycling between the trans-Golgi and the cell membranes. Accordingly,
Dagenais et al. [16] demonstrated in their patient abundant ATP7A
transcript levels but reduced levels of the corresponding truncated
protein, which they proposed to be predominantly located in the
plasma membrane. The phenotype was considered as consistent with
lysyl oxidase (LOX) – which is involved in collagen and elastin cross-
linking – being more sensitive than other cuproenzymes to copper de-
ﬁciency [16], as LOX needs copper during its synthesis in the en-
doplasmic reticulum.
Furthermore, by restricting the review to ATP7A truncating variants
aﬀecting either exon 22 or 23 [7–8,14,17–20], the present novel pa-
thogenic variant – as well as that of Dagenais et al. [16] – diﬀers from
the other truncations as it is predicted to preserve the eighth trans-
membrane domain (TMD8), introducing a stop codon just downstream
of the predicted TMD8 (Fig. 1I). Conversely, a frameshift variant at
position 1400, just 8 codons before the variant here described, but af-
fecting the TMD8, causes a classic MD [20]. This is consistent with the
fact that the structure of ATP7A transmembrane domains are extremely
conserved and even mild alterations are known to lead to marked re-
ductions in protein activity [8].
5. Conclusion
To our knowledge, the present report is the ﬁrst to display a non-
sense variation resulting in an ATP7A late truncation associated with
OHS rather than MD. The patient's phenotype suggests that ATP7A
retains a certain degree of residual activity when TMD8 remains intact,
despite the absence of the C-terminal 93 amino acids. The limit of
truncating variants with residual enzymatic activity can therefore be
shifted from exon 23 (codon 1451) to exon 22 (codon 1408). Moreover,
the patient's possibly aﬀected male relatives further support the idea
that the intrafamilial phenotypic variability might be very wide when
the variant has a residual enzymatic activity [4,21–23], and may be due
to diﬀerent expression of the mutant ATP7A, as previously demon-
strated [23]. As a consequence of OHS phenotypic variability, males
with ID and connective tissue abnormalities should be evaluated for
biochemical evidence of defective copper transport.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ymgmr.2017.07.007.
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